Systematic review and meta-analysis on the proportion of patients with breast cancer who develop bone metastases

Publication date: Available online 23 April 2017
Source:Critical Reviews in Oncology/Hematology
Author(s): Jean-Jacques Body, Geoffrey Quinn, Susan Talbot, Emma Booth, Gaston Demonty, Aliki Taylor, Justyna Amelio
A systematic literature review was conducted to quantify populations of patients with primary breast cancer in whom bone metastases were detected at study start or during follow-up. Searches were performed in PubMed and EMBASE using terms related to breast cancer and bone metastases. Articles had to have been published 01/01/99–31/12/13, and to report data on the proportion of patients with bone metastases among patients with breast cancer. In total, 156 articles were included in the meta-analysis. A median of 12% of patients with stage I–III breast cancer developed bone metastases during a median follow-up of 60 months. Of patients who developed metastatic disease during follow-up, 55% (median) had bone metastases. Of those with metastatic breast cancer at study start, 58% (median) had bone metastases. These data help to inform on the global burden of bone metastases by defining patient populations that are at risk of developing bone metastases.



from Cancer via ola Kala on Inoreader http://ift.tt/2pafXbc
via IFTTT